212 related articles for article (PubMed ID: 26912004)
21. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
[TBL] [Abstract][Full Text] [Related]
22. The inhibitory effect of acrylamide on NCAM expression in human neuroblastoma cells: involvement of CK2/Ikaros signaling pathway.
Lee HR; Cho SJ; Park HJ; Kim KH; Rhee DK; Pyo S
Toxicol In Vitro; 2010 Oct; 24(7):1946-52. PubMed ID: 20708675
[TBL] [Abstract][Full Text] [Related]
23. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros.
Son E; Do H; Joo HM; Pyo S
Nutrition; 2007 Oct; 23(10):745-53. PubMed ID: 17664058
[TBL] [Abstract][Full Text] [Related]
24. Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.
Nelson N; Szekeres K; Iclozan C; Rivera IO; McGill A; Johnson G; Nwogu O; Ghansah T
PLoS One; 2017; 12(2):e0170197. PubMed ID: 28152014
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
[TBL] [Abstract][Full Text] [Related]
26. Site-Specific Phosphorylation of Ikaros Induced by Low-Dose Ionizing Radiation Regulates Cell Cycle Progression of B Lymphoblast Through CK2 and AKT Activation.
Cho SJ; Kang H; Kim MY; Lee JE; Kim SJ; Nam SY; Kim JY; Kim HS; Pyo S; Yang KH
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1207-18. PubMed ID: 27026320
[TBL] [Abstract][Full Text] [Related]
27. Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia.
Ge Z; Gu Y; Han Q; Zhao G; Li M; Li J; Chen B; Sun T; Dovat S; Gale RP; Song C
Sci Rep; 2016 Nov; 6():38004. PubMed ID: 27885263
[TBL] [Abstract][Full Text] [Related]
28. Ikaros and tumor suppression in acute lymphoblastic leukemia.
Payne KJ; Dovat S
Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303
[TBL] [Abstract][Full Text] [Related]
29. Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.
Ge Z; Song C; Ding Y; Tan BH; Desai D; Sharma A; Gowda R; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Iyer S; Dhanyamraju PK; Imamura Y; Bogush D; Bamme Y; Yang Y; Soliman M; Kane S; Dovat E; Schramm J; Hu T; McGrath M; Chroneos ZC; Payne KJ; Gowda C; Dovat S
Leukemia; 2021 May; 35(5):1267-1278. PubMed ID: 33531656
[TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor Ikaros shapes the repertoire of notch target genes in T cells.
Geimer Le Lay AS; Oravecz A; Mastio J; Jung C; Marchal P; Ebel C; Dembélé D; Jost B; Le Gras S; Thibault C; Borggrefe T; Kastner P; Chan S
Sci Signal; 2014 Mar; 7(317):ra28. PubMed ID: 24643801
[TBL] [Abstract][Full Text] [Related]
31. The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia.
Zhou Y; Lian H; Shen N; Korm S; Kwok Ping Lam A; Layton O; Huiting LN; Li D; Miao K; Zeng A; Landesman-Bollag E; Seldin DC; Fu H; Hong L; Feng H
Haematologica; 2021 May; 106(5):1461-1465. PubMed ID: 32817283
[No Abstract] [Full Text] [Related]
32. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1.
Popescu M; Gurel Z; Ronni T; Song C; Hung KY; Payne KJ; Dovat S
J Biol Chem; 2009 May; 284(20):13869-13880. PubMed ID: 19282287
[TBL] [Abstract][Full Text] [Related]
33. Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis.
Nelson N; Xiang S; Zhang X; Gilvary D; Djeu J; Husain K; Malafa M; Vohra N; Pilon-Thomas S; Ghansah T
PLoS One; 2015; 10(1):e0115546. PubMed ID: 25629611
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways.
Piazza F; Manni S; Ruzzene M; Pinna LA; Gurrieri C; Semenzato G
Leukemia; 2012 Jun; 26(6):1174-9. PubMed ID: 22289987
[TBL] [Abstract][Full Text] [Related]
35. Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity.
Ding Y; Zhang B; Payne JL; Song C; Ge Z; Gowda C; Iyer S; Dhanyamraju PK; Dorsam G; Reeves ME; Desai D; Huang S; Payne KJ; Yue F; Dovat S
Leukemia; 2019 Nov; 33(11):2720-2731. PubMed ID: 31073152
[TBL] [Abstract][Full Text] [Related]
36. Functional interaction of protein kinase CK2 and activating transcription factor 4 (ATF4), a key player in the cellular stress response.
Ampofo E; Sokolowsky T; Götz C; Montenarh M
Biochim Biophys Acta; 2013 Mar; 1833(3):439-51. PubMed ID: 23123191
[TBL] [Abstract][Full Text] [Related]
37. Restoring Ikaros's wings to solve a leukemia maze.
Lobry C
Blood; 2015 Oct; 126(15):1735-6. PubMed ID: 26450952
[TBL] [Abstract][Full Text] [Related]
38. [Effect of Ikaros in B Cell Acute Lymphoblastic Leukemia].
Zhang HY; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1194-8. PubMed ID: 26314472
[TBL] [Abstract][Full Text] [Related]
39. Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.
Ge Z; Gu Y; Han Q; Sloane J; Ge Q; Gao G; Ma J; Song H; Hu J; Chen B; Dovat S; Song C
Epigenomics; 2018 Jan; 10(1):59-69. PubMed ID: 28994305
[TBL] [Abstract][Full Text] [Related]
40. Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase.
Ma H; Qazi S; Ozer Z; Zhang J; Ishkhanian R; Uckun FM
PLoS One; 2013; 8(8):e71302. PubMed ID: 23977012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
